These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
359 related articles for article (PubMed ID: 10564358)
21. Dopamine control of striatal gene expression during development: relevance to knockout mice for the dopamine transporter. Fauchey V; Jaber M; Bloch B; Le Moine C Eur J Neurosci; 2000 Sep; 12(9):3415-25. PubMed ID: 10998124 [TBL] [Abstract][Full Text] [Related]
22. Presynaptic control of striatal dopamine neurotransmission in adult vesicular monoamine transporter 2 (VMAT2) mutant mice. Patel J; Mooslehner KA; Chan PM; Emson PC; Stamford JA J Neurochem; 2003 May; 85(4):898-910. PubMed ID: 12716422 [TBL] [Abstract][Full Text] [Related]
23. Age-related and regional differences in dopamine transporter mRNA expression in human midbrain. Bannon MJ; Whitty CJ Neurology; 1997 Apr; 48(4):969-77. PubMed ID: 9109886 [TBL] [Abstract][Full Text] [Related]
24. Dopamine transporter (Dat) and synaptic vesicle amine transporter (VMAT2) gene expression in the substantia nigra of control and Parkinson's disease. Harrington KA; Augood SJ; Kingsbury AE; Foster OJ; Emson PC Brain Res Mol Brain Res; 1996 Feb; 36(1):157-62. PubMed ID: 9011752 [TBL] [Abstract][Full Text] [Related]
25. Expression of dopamine and vesicular monoamine transporters and differential vulnerability of mesostriatal dopaminergic neurons. González-Hernández T; Barroso-Chinea P; De La Cruz Muros I; Del Mar Pérez-Delgado M; Rodríguez M J Comp Neurol; 2004 Nov; 479(2):198-215. PubMed ID: 15452855 [TBL] [Abstract][Full Text] [Related]
26. Heterogeneous composition of dopamine neurons of the rat A10 region: molecular evidence for diverse signaling properties. Li X; Qi J; Yamaguchi T; Wang HL; Morales M Brain Struct Funct; 2013 Sep; 218(5):1159-76. PubMed ID: 22926514 [TBL] [Abstract][Full Text] [Related]
27. Differential regulation of glutamic acid decarboxylase mRNA and tyrosine hydroxylase mRNA expression in the aged manganese-treated rats. Tomás-Camardiel M; Herrera AJ; Venero JL; Cruz Sánchez-Hidalgo M; Cano J; Machado A Brain Res Mol Brain Res; 2002 Jun; 103(1-2):116-29. PubMed ID: 12106697 [TBL] [Abstract][Full Text] [Related]
28. Identification of dopamine plasma membrane and vesicular transporters in human peripheral blood lymphocytes. Amenta F; Bronzetti E; Cantalamessa F; El-Assouad D; Felici L; Ricci A; Tayebati SK J Neuroimmunol; 2001 Jul; 117(1-2):133-42. PubMed ID: 11431013 [TBL] [Abstract][Full Text] [Related]
29. Effect of the sonic hedgehog receptor smoothened on the survival and function of dopaminergic neurons. Zhou X; Pace J; Filichia E; Lv T; Davis B; Hoffer B; Selman W; Luo Y Exp Neurol; 2016 Sep; 283(Pt A):235-45. PubMed ID: 27317298 [TBL] [Abstract][Full Text] [Related]
30. Tyrosine hydroxylase and dopamine transporter expression following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurodegeneration of the mouse nigrostriatal pathway. Jakowec MW; Nixon K; Hogg E; McNeill T; Petzinger GM J Neurosci Res; 2004 May; 76(4):539-50. PubMed ID: 15114626 [TBL] [Abstract][Full Text] [Related]
31. Cell-type-specific expression of catecholamine transporters in the rat brain. Lorang D; Amara SG; Simerly RB J Neurosci; 1994 Aug; 14(8):4903-14. PubMed ID: 8046459 [TBL] [Abstract][Full Text] [Related]
32. Selective alterations of gene expression in mice induced by MPTP. Xu Z; Cawthon D; McCastlain KA; Slikker W; Ali SF Synapse; 2005 Jan; 55(1):45-51. PubMed ID: 15499605 [TBL] [Abstract][Full Text] [Related]
33. Perinatal delta9-tetrahydrocannabinol exposure did not alter dopamine transporter and tyrosine hydroxylase mRNA levels in midbrain dopaminergic neurons of adult male and female rats. García-Gil L; Ramos JA; Rubino T; Parolaro D; Fernández-Ruiz JJ Neurotoxicol Teratol; 1998; 20(5):549-53. PubMed ID: 9761594 [TBL] [Abstract][Full Text] [Related]
35. Striatal dopaminergic and serotonergic markers in human heroin users. Kish SJ; Kalasinsky KS; Derkach P; Schmunk GA; Guttman M; Ang L; Adams V; Furukawa Y; Haycock JW Neuropsychopharmacology; 2001 May; 24(5):561-7. PubMed ID: 11282256 [TBL] [Abstract][Full Text] [Related]
36. Reduced tyrosine hydroxylase and GTP cyclohydrolase mRNA expression, tyrosine hydroxylase activity, and associated neurochemical alterations in Nurr1-null heterozygous mice. Eells JB; Misler JA; Nikodem VM Brain Res Bull; 2006 Jun; 70(2):186-95. PubMed ID: 16782508 [TBL] [Abstract][Full Text] [Related]
37. Reduced expression of the molecular markers of dopaminergic neuronal atrophy in the aging rat brain. Himi T; Cao M; Mori N J Gerontol A Biol Sci Med Sci; 1995 Jul; 50(4):B193-200. PubMed ID: 7614230 [TBL] [Abstract][Full Text] [Related]
38. Methamphetamine-induced degeneration of dopaminergic neurons involves autophagy and upregulation of dopamine synthesis. Larsen KE; Fon EA; Hastings TG; Edwards RH; Sulzer D J Neurosci; 2002 Oct; 22(20):8951-60. PubMed ID: 12388602 [TBL] [Abstract][Full Text] [Related]
39. Reduced gene expression for dopamine biosynthesis and transport in midbrain neurons of adult male rats exposed prenatally to ethanol. Szot P; White SS; Veith RC; Rasmussen DD Alcohol Clin Exp Res; 1999 Oct; 23(10):1643-9. PubMed ID: 10549997 [TBL] [Abstract][Full Text] [Related]
40. Delayed plasticity of the mesolimbic dopamine system following neonatal 6-OHDA lesions. Frohna PA; Neal-Beliveau BS; Joyce JN Synapse; 1997 Mar; 25(3):293-305. PubMed ID: 9068128 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]